Benzinga | Jul 16, 2020 07:13AM EDT

Canaccord Genuity Initiates Coverage On Repro-Med Systems with Buy Rating, Announces Price Target of $13

Canaccord Genuity analyst Kyle Rose initiates coverage on Repro-Med Systems (NASDAQ:KRMD) with a Buy rating and announces Price Target of $13.